Země: Spojené státy
Jazyk: angličtina
Zdroj: NLM (National Library of Medicine)
benazepril hydrochloride (UNII: N1SN99T69T) (benazepril - UNII:UDM7Q7QWP8)
Rebel Distributors Corp.
benazepril hydrochloride
benazepril hydrochloride 5 mg
ORAL
PRESCRIPTION DRUG
Benazepril hydrochloride tablets are indicated for the treatment of hypertension. They may be used alone or in combination with thiazide diuretics. In using benazepril hydrochloride tablets, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. Available data are insufficient to show that benazepril hydrochloride does not have a similar risk (see WARNINGS ). Black patients receiving ACE inhibitors have been reported to have a higher incidence of angioedema compared to nonblacks. It should also be noted that in controlled clinical trials ACE inhibitors have an effect on blood pressure that is less in black patients than in nonblacks. Benazepril hydrochloride tablets are contraindicated in patients who are hypersensitive to this product or to any other ACE inhibitor.
Benazepril Hydrochloride Tablets are available as: 5 mg: yellow-orange, round, biconvex, film coated tablets, debossed “E” over “5” on one side and plain on the other. 10 mg: orange, round, biconvex, film coated tablets, debossed “E” over “53” on one side and plain on the other. 20 mg: pink, round, biconvex, film coated tablets, debossed “E” over “82” on one side and plain on the other. 40 mg: red, round, biconvex, film coated tablets, debossed “E” over “48” on one side and plain on the other. Benazepril Hydrochloride Tablets, 5 mg, 10 mg, 20 mg and 40 mg, packaged with a desiccant, are available in bottles of 90, 100 and 500 tablets. Store at 20º to 25º C (68º to 77º F) [see USP Controlled Room Temperature]. Protect from moisture. Dispense contents in a tight, light-resistant container as defined in the USP with a child-resistant closure, as required. To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. Sandoz Inc. Princeton, NJ 08540 Repackaged by: Rebel Distributors Corp. Thousand Oaks, CA 91320 OS8016 Rev. 01/09 MF0005REV01/09 MG #17815
Abbreviated New Drug Application
BENAZEPRIL HYDROCHLORIDE- BENAZEPRIL HYDROCHLORIDE TABLET, FILM COATED BENAZEPRIL HYDROCHLORIDE- BENAZEPRIL HYDROCHLORIDE TABLET, FILM COATED REBEL DISTRIBUTORS CORP. ---------- BENAZEPRIL HYDROCHLORIDE TABLETS 5 MG, 10 MG, 20 MG AND 40 MG RX ONLY USE IN PREGNANCY WHEN USED IN PREGNANCY, ACE INHIBITORS CAN CAUSE INJURY AND EVEN DEATH TO THE DEVELOPING FETUS. When pregnancy is detected, benazepril hydrochloride tablets should be discontinued as soon as possible. See WARNINGS, FETAL/NEONATAL MORBIDITY AND MORTALITY. DESCRIPTION Benazepril hydrochloride is a white to off-white crystalline powder, soluble (>100 mg/mL) in water, in ethanol and in methanol. Its chemical name is 3-[[1-(ethoxy-carbonyl)-3-phenyl-(1S)-propyl]amino]- 2,3,4,5-tetrahydro-2-oxo-1_H_-1-(3S)-benzazepine-1-acetic acid monohydrochloride; its structural formula is: Its molecular formula is C H N O HCl and its molecular weight is 460.96. Benazeprilat, the active metabolite of benazepril, is a non-sulfhydryl angiotensin-converting enzyme inhibitor. Benazepril is converted to benazeprilat by hepatic cleavage of the ester group. Benazepril hydrochloride is supplied as tablets containing 5 mg, 10 mg, 20 mg and 40 mg of benazepril hydrochloride for oral administration. The inactive ingredients are lactose monohydrate, microcrystalline cellulose, pregelatinized starch, hydrogenated castor oil, crospovidone, colloidal silicon dioxide, zinc stearate, hypromellose, titanium dioxide, polyethylene glycol 400 and polysorbate 80. The 5 MG and 10 MG tablets also contain D&C yellow No. 10 and FD&C yellow No. 6. The 20 MG tablets also contain FD&C red No. 40 and FD&C yellow No. 6. The 40 MG tablets also contain FD&C red No. 40. CLINICAL PHARMACOLOGY MECHANISM OF ACTION Benazepril and benazeprilat inhibit angiotensin-converting enzyme (ACE) in human subjects and animals. ACE is a peptidyl dipeptidase that catalyzes the conversion of angiotensin I to the vasoconstrictor substance, angiotensin II. Angiotensin II also stimulates aldosterone secretion by the adrenal co Přečtěte si celý dokument